T-cell interactions with extracellular matrix proteins and endothelium in chronic renal allograft rejection.
Korczak-Kowalska
G
G
Transplantation Institute, Warsaw Medical School, Poland.
Nowaczyk
M
M
Stepién-Sopniewska
B
B
Morzycka-Michalik
M
M
Mrowiec
T
T
Wierzbicki
P
P
Paczek
L
L
Durlik
M
M
Wyzgał
J
J
Matysiak
W
W
Górski
A
A
D001707:Biopsy, Needle; D002448:Cell Adhesion; D002460:Cell Line; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000276:immunology*; D016326:Extracellular Matrix Proteins / Q000032:analysis / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008833:Microcirculation; D016853:Muromonab-CD3; D010835:Phytohemagglutinins; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D016326:Extracellular Matrix Proteins; D008070:Lipopolysaccharides; D016853:Muromonab-CD3; D010835:Phytohemagglutinins; D013755:Tetradecanoylphorbol Acetate